13F

Stock

Eagle Pharmaceuticals In

Ticker not mapped · held by 2 managers

Reported value

$4.21K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$4.43K

Price effect on 2 books still in the name

Largest holder

$4.09K

Stanley-Laman Group, Ltd.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Stanley-Laman Group, Ltd.12K$4.09K−$4.31KCut−$4.31K
Archer Investment Corp350$119−$126Cut−$126

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.